NEW

Activ Surgical Announces FDA Clearance for ActivSight Intraoperative Imaging Module

Activ Surgical announced the U.S. Food and Drug Administration (FDA) 510(k) clearance of the company’s ActivSight Intraoperative Imaging Module for enhanced surgical visualization.

Metrex Surface Disinfectant Portfolio Secures EPA Approval

The U.S. Environmental Protection Agency (EPA) has approved all eight surface disinfectant products made by an infection prevention leader, Metrex, as effective against SARS-CoV-2, the novel coronavirus that causes COVID-19.

Olympus Supports Safety Actions Regarding Surgical Smoke

Olympus has announced its support of The Joint Commission’s recommended safety actions for managing the hazards of exposure to surgical smoke for health care staff in operating rooms.

Exofin Fusion Redesign Receives FDA Approval

Chemence Medical, a leader in medical cyanoacrylate devices and products, announced the U.S. Federal Drug Administration’s (FDA) 510(k) approval of the company’s redesigned exofin fusion skin closure system.

UVDI V-MAX UV-C Technology Proven Effective

UVDI V-MAX UV-C Technology Proven Effective

UltraViolet Devices Inc. (UVDI) announced its V-MAX UV-C air disinfection technology has achieved 99.99% inactivation of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) in a single-pass in moving airstream HVAC testing. The testing was conducted at Innovative Bioanalysis, a BEI-recognized BSL-3 laboratory in California.

In the independent testing, UVDI V-MAX UV-C air disinfection technology eliminated 99.99% of SARS-CoV-2 in a single pass at an airflow rate of 500 feet per minute. To confirm effectiveness against airborne SARS-CoV-2 in a moving airstream, Innovative Bioanalysis used a HVAC duct test based on a modified ISO 15714 and ASHRAE 185.1 standard. To replicate conditions in a typical HVAC duct, UVDI V-MAX 254 nm UV-C lamps were arranged in a parallel configuration.

“This novel testing underlines UVDI’s UV-C technology’s effectiveness against airborne SARS-CoV-2,” stated Dr. Ashish Mathur, Ph.D., UVDI vice president of innovation and technology. “The study results are further evidence that UVDI provides proven airstream protection – and peace-of-mind – for critical infrastructure globally such as airports, health care facilities, schools and government buildings as well as for high-traffic public spaces such as arenas, sports facilities and hospitality sites.”

UVDI’s V-MAX UV-C air disinfection technology works by damaging the DNA of microorganisms, eliminating their ability to reproduce and infect people. UV-C air disinfection product effectiveness against coronavirus is currently supported using established models to estimate the UV-C dose required to inactivate the virus. The BSL-3 laboratory results also confirm the accuracy of UVDI’s proprietary modelling software, which determines custom product configurations for targeted UV-C effectiveness. The software was used to inform the study’s protocols.

“UVDI is committed to doing all we can to help people get back to normal as quickly and safely as possible, whether at work, in school or travelling,” added Peter Veloz, UVDI chief executive officer. “Providing clean, disinfected air is core to this mission and relies on the highest levels of scientific proof. We are proud that UVDI’s advanced UV-C air and surface disinfection products have now both been proven to inactivate SARS-CoV-2 in rigorous, innovative and independent laboratory testing.”

For more information, visit UVDI.com.

Previous

Next

Submit a Comment

Your email address will not be published. Required fields are marked *

X